References

Frequency of chloroquine-resistant haplotype of Plasmodium falciparum (CVIET) in Ibadan, southwest Nigeria 17 years post-chloroquine withdrawal

10.1016/j.actatropica.2024.107435 · 2024 · External reference

Antibiotic resistance and its cost: is it possible to reverse resistance?

10.1038/nrmicro2319 · 2010 · External reference

Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites

10.1016/j.ijpddr.2018.05.003 · 2018 · External reference

Dolutegravir as first-line antiretroviral therapy in South Africa: beware the one-size-fits-all approach

10.7196/samj.2022.v112i10.16596 · 2022 · External reference

Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis

10.1016/s1473-3099(17)30325-0 · 2017 · External reference

Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man

10.1093/jac/dki332 · 2005 · External reference

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso

10.1038/s41598-024-75369-2 · 2024 · External reference

Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in southeast of Tanzania

10.1038/s41598-020-60549-7 · 2020 · External reference

Selective bird predation on the peppered moth: the last experiment of Michael Majerus

10.1098/rsbl.2011.1136 · 2012 · External reference

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia

10.1056/nejm200102153440702 · 2001 · External reference

Artemisinin resistance in Plasmodium falciparum malaria

10.1056/nejmoa0808859 · 2009 · External reference

Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction

10.1016/s0140-6736(00)04519-0 · 2001 · External reference

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1

10.7554/elife.10670 · 2016 · External reference

Tuberculosis in New York city—turning the tide

10.1056/nejm199507273330406 · 1995 · External reference

Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data

10.1186/1475-2875-10-116 · 2011 · External reference

In-vivo efficacy of chloroquine to clear asymptomatic infections in mozambican adults: a randomized, placebo-controlled trial with implications for elimination strategies

10.1038/s41598-017-01365-4 · 2017 · External reference

Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting

10.1086/605530 · 2009 · External reference

Parallel rise and fall of melanic peppered moths in America and Britain

10.1093/oxfordjournals.jhered.a023013 · 1996 · External reference

In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes

10.1128/aac.02306-12 · 2013 · External reference

Estimating the fitness cost and benefit of antimicrobial resistance from pathogen genomic data

10.1098/rsif.2023.0074 · 2023 · External reference

Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study

10.1186/1471-2458-13-782 · 2013 · External reference

Counter-selection of antimalarial resistance polymorphisms by intermittent preventive treatment in pregnancy

10.1093/infdis/jiz451 · 2020 · External reference

Evolution of multidrug resistance in Plasmodium falciparum: a longitudinal study of genetic resistance markers in the greater mekong subregion

10.1128/aac.01121-21 · 2021 · External reference

Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections

10.1056/nejmoa1007474 · 2011 · External reference

Differential persistence of transmitted HIV-1 drug resistance mutation classes

10.1093/infdis/jiq167 · 2011 · External reference

Factors affecting the reversal of antimicrobial-drug resistance

10.1016/s1473-3099(09)70105-7 · 2009 · External reference

Insights into durability against resistance from the antibiotic nitrofurantoin

10.1038/s44259-024-00056-1 · 2024 · External reference

Longitudinal monitoring reveals persistence of colistin-resistant Escherichia coli on a pig farm following cessation of colistin use

10.3389/fvets.2022.845746 · 2022 · External reference

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

10.1086/375419 · 2003 · External reference

Return of chloroquine antimalarial efficacy in Malawi

10.1056/nejmoa062032 · 2006 · External reference

Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites

10.1086/655659 · 2010 · External reference

Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: a decade-long experience

10.1017/ice.2018.245 · 2018 · External reference

Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China

1995 · External reference

mcr-1 and plasmid prevalence in Escherichia coli from livestock

10.1016/s1473-3099(20)30697-6 · 2020 · External reference

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

10.1056/nejmoa062876 · 2007 · External reference

Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission

10.1097/01.aids.0000222071.60620.1d · 2006 · External reference

Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital

10.1007/s11096-006-9059-x · 2007 · External reference

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 seroconverter study cohort

10.1371/journal.pone.0209605 · 2019 · External reference

Unresolved reference

2026 · External reference

Steep rebound of chloroquine-sensitive Plasmodium falciparum in Zimbabwe

10.1093/infdis/jiaa368 · 2021 · External reference

Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

10.1186/1471-2458-11-19 · 2011 · External reference

Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia

10.1186/s12936-021-03859-z · 2021 · External reference

Trends in drug-resistant Mycobacterium tuberculosis in New York city, 1991–2003

10.1086/504325 · 2006 · External reference

Nonadherence in Tuberculosis treatment: predictors and consequences in New York city

10.1016/s0002-9343(96)00402-0 · 1997 · External reference

In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine

10.1128/jvi.02154-08 · 2009 · External reference

Adaptive evolution of malaria parasites in French guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt

10.1073/pnas.1507142112 · 2015 · External reference

Explaining the stable coexistence of drug-resistant and -susceptible pathogens: the resistance acquisition purifying selection model

10.1016/j.epidem.2025.100848 · 2025 · External reference

Trends in infection incidence and antimicrobial resistance in the US veterans affairs healthcare system: a nationwide retrospective cohort study (2007–22)

10.1016/s1473-3099(24)00416-x · 2024 · External reference

A SYBR green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs

10.1186/1475-2875-12-450 · 2013 · External reference

10.21203/rs.3.rs-2072289/v1

10.21203/rs.3.rs-2072289/v1 · 2022 · External reference

Longitudinal study on the occurrence in pigs of colistin-resistant Escherichia coli carrying mcr-1 following the cessation of use of colistin

10.1111/jam.13907 · 2018 · External reference

Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996–2016

10.1016/j.cmi.2017.06.014 · 2018 · External reference

Unresolved reference

2010 · External reference

The effect of antibiotic restriction programs on prevalence of antimicrobial resistance: a systematic review and meta-analysis

10.1093/ofid/ofab070 · 2021 · External reference

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland

10.1056/nejm199708143370701 · 1997 · External reference

Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological study

10.1016/s2666-5247(20)30005-7 · 2020 · External reference

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use

10.1093/jac/dkp387 · 2010 · External reference

Fluoroquinolone stewardship at a community health system: a decade in review

10.1017/ash.2022.326 · 2022 · External reference

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

10.1073/pnas.90.12.5653 · 1993 · External reference

10.1101/2024.06.03.597162

10.1101/2024.06.03.597162 · 2024 · External reference

Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand

10.1086/509809 · 2007 · External reference

Decreased colistin resistance and mcr-1 prevalence in pig-derived Escherichia coli in Japan after banning colistin as a feed additive

10.1016/j.jgar.2021.01.016 · 2021 · External reference

The impact of sulfadoxine–pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: an updated systematic review and meta-analysis

10.1016/s1473-3099(25)00219-1 · 2025 · External reference

The industrial melanism mutation in British peppered moths is a transposable element

10.1038/nature17951 · 2016 · External reference

Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China

10.4269/ajtmh.2005.72.410 · 2005 · External reference

Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study

10.1016/s1473-3099(20)30149-3 · 2020 · External reference

Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion

10.1038/s41467-025-59946-1 · 2025 · External reference

The development and spread of drug-resistant malaria

10.1016/0169-4758(91)90262-m · 1991 · External reference

Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: a modelling study

10.1371/journal.pmed.1002416 · 2017 · External reference

Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum

10.1038/nature00813 · 2002 · External reference

Brief antibiotic use drives human gut bacteria towards low-cost resistance

10.1038/s41586-025-08781-x · 2025 · External reference

Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya

10.1186/s12936-022-04284-6 · 2022 · External reference